Opportunities in Regenerative Medicine, Cancer Immunotherapy Markets for Value Investors
July 06, 2015
Jason Kolbert
Handpicked Stocks in Emerging Pharmaceuticals
November 24, 2014
Moussatos, Liana
Managing a Growth Portfolio with a Focus on Company-Specific Metrics
September 08, 2014
Sansoterra, Michael A.
Seeking Growth at a Reasonable Price While Considering Secular Themes
May 02, 2014
Wehner, Diane M.
Biotechnology Capital Inflows Reach Historic Highs
April 07, 2014
Skorney, Brian
Increased Biotech Productivity and Innovation Reflected in FDA-Approved Drugs
August 23, 2013
Tenthoff, Ted
Opportunities in Hepatitis C and Genomic Technologies
April 08, 2013
Ferreiro, David
FDA Approvals Accelerate and Opportunities Arise in Hepatitis C Market
April 08, 2013
Skorney, Brian
Hepatitis C Therapies Propel Growth in Biotech
August 30, 2012
Roden, Matthew
Defensive Plays In The Defense Space - Michael F. Ciarmoli - Keybanc Capital Markets Inc.
November 14, 2011
Ciarmoli, Michael F.
"common Sense" Investment Management - Kendall J. Anderson - Anderson Griggs Portfolio Management
November 14, 2011
Anderson, Kendall J.
Investing In Small- & Midcap Biotech Companies - Dr. Jason Kantor - Rbc Capital Markets
April 04, 2011
Kantor, Jason
Health Care Services & Tech Outlook - Ross Muken - Deutsche Bank Securities, Inc.
November 15, 2010
Muken, Ross
Overview Of Midwestern Regional Bank Metrics - Craig Siegenthaler - Credit Suisse
April 05, 2010
Siegenthaler, Craig
Update On Science Tools & Diagnostics - Isaac Ro - Leerink Swann & Company
January 25, 2010
Ro, Isaac
Investing In Regulated Electric Utilities - Marc De Croisset - Macquarie Capital (usa) Inc.
May 18, 2009
De Croisset, Marc
Sector-focused Growth Management - Frank Mastrapasqua & Mauro M. Mastrapasqua - Mastrapasqua Asset Management
June 09, 2008
K.CRONK / T.LAPOINTE - COLUMBIA MANAGEMENT GROUP
June 27, 2005
KEVIN CAREY - 1ST SOURCE CORPORATION INVESTMENT ADVISORS INC
July 19, 2004
Carey, Kevin A.
JONATHAN ROTHBERG - CURAGEN CORPORATION (CRGN)
March 08, 2004
Rothberg, Jonathan M.
L.holtz / Y.lipsker - Roger Engemann & Associates
July 28, 2003
Lipsker, Yossi, Holtz, Lou
Large Cap Biotechnology & Life Sciences: Ronald Renaud - Bear, Stearns & Co
September 13, 2002
Renaud, Ronald C.
Wayne Yetter - Synavant Inc (snvt)
September 13, 2002
Yetter, Wayne
Ian Smith - Vertex Pharmaceuticals Inc (vrtx)
June 02, 2002
Smith, Ian F.
R.schwarzkopf / S.gleason - Kayne Anderson Rudnick Investment Mgmt Llc
February 25, 2002
Gleason, Sandi L., Schwarzkopf, Robert A.
George Robson - Dendrite International (drte)
September 14, 2001
Robson, George
Japanese Semiconductor Companies & Electronics: Scott Foster - Lehman Brothers
September 12, 2001
Foster, Scott
Mary Ann Gray - Federated Kaufmann Fund
June 07, 2001
Gray, Mary Ann
Mark Frevert - Enron Wholesale Services (ene)
May 31, 2001
Frevert, Mark A.
Outlook For Biotechnology Stocks: William Slattery - Deerfield Management
December 18, 2000
Slattery, William
D.altabef / D.katz - Matrix Asset Advisors
December 18, 2000
Altabef, Douglas S., Katz, David A.
George Kellner - Kellner, Dileo & Co
November 20, 2000
Kellner, George A.
Emerging Pharamaceutical Companies : Corey Davis - Chase H&q
January 13, 2000
Davis, Corey
Joe C. Cook Jr. - Amylin Pharmaceuticals (amln)
January 13, 2000
Cook, Joe C.
Ian Prosser - Bass Plc (bass.l)
January 03, 2000
Prosser, Sir Ian
Roundtable Forum: Major Chemicals
December 20, 1999
Semegran, Theodore (Ted) S., Leming, Paul T., Roberts, John E., Mitsch, Frank J.
Biotherapeutics Stocks : Michael G. King Jr. - Robertson Stephens
December 06, 1999
King, Michael G.
